Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Synlait Milk receives MPI approval

SYNLAIT MILK LIMITED

MEDIA RELEASE

28 August 2014

Synlait Milk receives MPI approval

Synlait Milk has received approval of its Risk Management Programme from the Ministry for Primary Industries (MPI) for its dry blending and consumer packaging plant.

The approval enables Synlait Milk to now pack and export retail-ready product from its manufacturing site, having met the New Zealand food safety requirements of the Animal Products Act 1999.

The only exception is for exports of finished infant formula to China. Documentation required to support Synlait Milk’s application for registration as an exporter of finished infant formula to China was sent to the Chinese regulatory body today by MPI.

Managing Director Dr John Penno said it’s a major milestone towards meeting customer demand for total product integrity from grass to glass.

“Today is an important day for our business. We now have an integrated facility on one site that gives us full manufacturing control and delivers on the needs of consumers looking for nutritious and safe food,” said Dr Penno.

“The packaging plant provides further support for our value added strategy of supplying high quality finished infant formula and nutritional products to our customers.

“We look forward with confidence to working with authorities in New Zealand and China to achieve registration as soon as possible.”

The sophisticated packaging plant was built in nine months at a cost of $28.5 million and is the only one of its kind in the South Island, New Zealand. It has a processing capacity of 30,000 metric tonnes per annum, or around 33 million 900 gram cans of powder.

ENDS

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.